MAPT and Alzheimer disease: This spectral formulation enables robust learning of spatiotemporal dynamics of amyloid, tau, neurodegeneration, and cognitive decline from longitudinal imaging and biomarker data within the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort.